Received Apr 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 92nn/mg529 | IM |
Per patient, she developed a rash within 24 hours of receiving the vaccine. Vaccine was administered on 4/16/25 and reaction began 4/17/25. On 4/18/25, she developed facial swelling and noticed skin drying and cracking. Patient called at 5pm on 4/19/25 to report adverse event to pharmacy and was instructed to seek medical attention as soon as possible. Rash and some swelling is ongoing, but patient reported some relief when taking Benadryl.
None
Psoriasis, ADHD, Anxiety
Adderall IR, Aripiprazole, Lorazepam, Lamotrigine
No known allergies